Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Anti-SARS-CoV-2 (COVID 19) and Encapsulated Vaccination in a Cohort of Patients With Thalassemic and Falcemic Syndromes

NCT05157256 is registered in ClinicalTrials.gov with Società Italiana Talassemie ed Emoglobinopatie as lead sponsor.

NCT NCT05157256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Anti-SARS-CoV-2 (COVID 19) and Encapsulated Vaccination in a Cohort of Patients With Thalassemic and Falcemic Syndromes
Lead sponsor
Società Italiana Talassemie ed Emoglobinopatie
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2022
Completion date
December 31, 2030
Enrollment
1,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection, thalasemmie, scd